Latest Biovica International News & Updates

See the latest news and media coverage for Biovica. We track all announcements, press releases, and industry mentions in real time, all in one place.

Biovica International (Biovica)

Developer of blood tests for cancer monitoring

Latest news about Biovica International (Biovica)

May 1 Biovica

Biovica welcomes Theis Kipling as CEO

Theis brings significant leadership experience to lead Biovica into its next phase, building on scientific foundation, clinical progress, and commercial opportunities.
April 30 Biovica

Biovica announces three ESMO posters highlighting TKa

The posters demonstrate TKa's use in monitoring treatment response and progression in metastatic breast cancer settings. They support TKa as a biomarker for patient management and drug development.
April 16 Biovica

Biovica announces Theis Kipling as CEO on May 1, 2026

Anders Rylander steps down as CEO and stays on the Board. The transition accelerates earlier than planned.
April 7 Biovica

Biovica appoints Theis Kipling as new CEO

He will assume the position no later than September 2026, bringing extensive experience from life sciences and diagnostics. Current CEO Anders Rylander steps down after 15 years.

April 30 Yahoo Finance

New ESMO Data Highlights TKa Across Multiple Treatment Settings

UPPSALA, SE / ACCESS Newswire / April 30, 2026 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) - Biovica today announces that three posters including TKa measurements...
April 16 Yahoo Finance

Theis Kipling to Assume Role as CEO of Biovica on May 1, 2026

UPPSALA, SE / ACCESS Newswire / April 16, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica today announces that Theis Kipling will assume the role as...
April 7 Yahoo Finance

Theis Kipling New CEO for Biovica

UPPSALA, SE / ACCESS Newswire / April 7, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - The Biovica board has appointed Theis Kipling as the new Chief...
March 18 Morningstar

New AACR Data Expand Evidence for TKa In Immunotherapy-Treated Patients and CDK Inhibitor Dose Optimization

Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based biomarkers for cancer treatment monitoring, today announces two poster presentations at the American Association for Cancer...

Never miss news about Biovica

Track Biovica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Browse news for competitors to Biovica and other trending companies.